Please wait…

Login required

Username or email:

To use this function please log-in
If you haven't got an account on, you have the opportunity to register regist here for free.

add instrument

DKB Pharma Fonds TNL

DKB Pharma Fonds TNL

ISIN LU0117118041 | WKN 541954 | Mnemonic DKEB | Type fund
14/06/2019 17:23
Bid Ask
This product is subject to quotation restrictions.
Change from Prev. Day -0.13 EUR / -0.20%
Spread absolute / relative 0,94 / 1,48%

Net Asset Value

Previous Day 63.72 EUR Date 14/06/2019

Price Information

Last Price 63.4800
Date / Time 14.06.2019 / 17:23:17
Price -
Volume in euro -
Volume Size -
High 63.480
Low 63.200
52 week High 65.750
52 week Low 56.610
Trading Hours 09:00 - 18:00

Price History

Date Opening Price Closing Price Daily High Daily Low Volume (pcs.)
14/06/2019 63.2400 63.4800 63.4800 63.2000
13/06/2019 63.6100 63.6100 63.6100 63.6100
12/06/2019 63.2100 63.2000 63.2100 63.1600
11/06/2019 63.4600 63.4600 63.4600 63.4600
07/06/2019 62.8100 62.8700 62.8700 62.8100


Management Fee 1.40 %
Custodian Fee 0.10 %
Capital forming savings possible? no
Savings Plan no
Distribution Non Distributing

Frankfurt Trading Parameters

Continous Quotation no
Minimum tradeable Unit 1

Rating for DKB Pharma Fonds TNL

€uro FondsNote 3
Lipper Leaders, 3 years -
Lipper Leaders, 5 years -
Lipper Leaders, 10 years -
Lipper Leaders, overall -


Fundamental Data

WKN 541954
ISIN LU0117118041
Name DKB Pharma Fonds TNL
Investment Company BayernInvest (Lux)
Issued in Luxemburg
Issue Date 29/08/2000
Category Aktienfonds Pharma + Gesundheit
currency EUR
Volume 27,370,716.36
Depositary Bank Banque LBLux S.A.
Paying Agent Deutsche Kredit AG
Fund Management Bayern-Invest Kapitalanlagegesellschaft mbH
Fiscal Year-End 31.03.
Last Update 21/10/2011

Investment policy

invest like DKB Pharma Fonds TNL: Ziel der Anlagepolitik ist die Erwirtschaftung einer attraktiven Rendite durch Erträge und Kapitalgewinne aus Aktienanlagen in ertrags- und wachstumsstarken Unternehmen. Der Fonds investiert mindestens 51% in Pharma- bzw. Gesundheits- oder Health-Care-Unternehmen aus der ganzen Welt. Daneben wird auch in die hochinnovative Branche der Bio- und Gentechnologie, in überdurchschnittlich stark expandierende Gesundheitsdienstleistungs- und Medizintechnologieunternehmen sowie in Unternehmen mit medizinischen Ernährungsprodukten investiert.

The following Disclaimer and Information has been prepared by Voltabox AG (the “Issuer”) for the purpose of publishing THE securities prospectus by the issuer. Deutsche Boerse AG does not assume any responsibility for the content of the issuer`s Disclaimer and information.


Important Information


The information contained on the following web pages is directed only at persons who are resident of or domiciled in the Federal Republic of Germany (“Germany”) or the Grand Duchy of Luxembourg (“Luxembourg”). The following information does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities. No offer of securities of the Issuer is being, or will be, made to the public outside Germany and Luxembourg. The offer in Germany and Luxembourg is being made solely on the basis of the securities prospectus (including any amendments thereto) which has been approved by the German Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and which has been published on the Issuer’s website. Any investment decision regarding the publicly offered securities of the Issuer should only be made on the basis of the securities prospectus. The securities prospectus is available free of charge from the Issuer (Artegastraße 1, 33129 Delbrück, Germany; Tel.: +49 (0)5250 9930-900; Fax: +49 (0)5250 9762-102) and on the Issuer’s website (

The information contained on the following web pages is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States of America (“United States”), Canada, Australia or Japan. The Issuer’s shares, and the securities offered in the course of the offer, have not been and will not be registered under the US Securities Act of 1933, as amended (“Securities Act”), or with any other securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold or delivered within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The Issuer does not intend to register the offer or parts thereof in the United States or make an offer to the public in the United States, Canada, Australia or Japan.

The information contained on the following web pages is not for distribution to persons who are located in the United States, Canada, Australia or Japan or any other jurisdiction where the offer of the securities to the public is not taking place. Any violation of these restrictions may constitute a breach of the securities laws of these countries. The copying, forwarding or other transmission of the content of the following web pages is prohibited.

By clicking the "I AGREE" button below, you warrant that (i) you have read and accepted the foregoing information and restrictions in full and (ii) you are a resident of or domiciled in Germany or Luxembourg, and (iii) you agree not to distribute or forward the information contained on the following web pages to any person who is not a resident of or domiciled in Germany or Luxembourg.


We regret that, due to regulatory restrictions, we are unable to provide you with access to the following web pages.